| Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
| 1
|
COVID-19 pandemic
|
194,267
|
6,266
|
GA
|
Top
|
| 2
|
COVID-19
|
144,472
|
4,660
|
B
|
Top
|
| 3
|
Hand, foot, and mouth disease
|
112,820
|
3,639
|
B
|
High
|
| 4
|
Rabies
|
92,969
|
2,999
|
B
|
Top
|
| 5
|
Polio
|
86,209
|
2,780
|
B
|
Top
|
| 6
|
List of epidemics and pandemics
|
85,728
|
2,765
|
List
|
High
|
| 7
|
HIV/AIDS
|
84,703
|
2,732
|
GA
|
Top
|
| 8
|
Smallpox
|
83,270
|
2,686
|
GA
|
Top
|
| 9
|
Spanish flu
|
81,893
|
2,641
|
GA
|
Top
|
| 10
|
Norovirus
|
74,271
|
2,395
|
B
|
Top
|
| 11
|
Human papillomavirus infection
|
71,418
|
2,303
|
B
|
Top
|
| 12
|
Epstein–Barr virus
|
70,418
|
2,271
|
B
|
Top
|
| 13
|
Creutzfeldt–Jakob disease
|
69,805
|
2,251
|
B
|
Top
|
| 14
|
Shingles
|
66,881
|
2,157
|
GA
|
Top
|
| 15
|
HIV
|
58,776
|
1,896
|
GA
|
Top
|
| 16
|
Measles
|
57,568
|
1,857
|
B
|
Top
|
| 17
|
Prion
|
57,301
|
1,848
|
GA
|
Top
|
| 18
|
Hodgkin lymphoma
|
56,525
|
1,823
|
B
|
Top
|
| 19
|
Infectious mononucleosis
|
54,811
|
1,768
|
B
|
Top
|
| 20
|
Chikungunya
|
52,737
|
1,701
|
B
|
High
|
| 21
|
Virus
|
51,160
|
1,650
|
FA
|
Top
|
| 22
|
Influenza
|
51,036
|
1,646
|
FA
|
Top
|
| 23
|
Mosquito
|
49,000
|
1,580
|
GA
|
Mid
|
| 24
|
Dengue fever
|
48,401
|
1,561
|
FA
|
Top
|
| 25
|
Chronic wasting disease
|
48,192
|
1,554
|
B
|
Top
|
| 26
|
Molluscum contagiosum
|
43,498
|
1,403
|
B
|
High
|
| 27
|
COVID-19 pandemic in the United States
|
42,893
|
1,383
|
B
|
Low
|
| 28
|
Respiratory syncytial virus
|
42,100
|
1,358
|
B
|
High
|
| 29
|
Bell's palsy
|
40,965
|
1,321
|
B
|
Top
|
| 30
|
Chickenpox
|
39,358
|
1,269
|
B
|
Top
|
| 31
|
Herpes
|
38,502
|
1,242
|
GA
|
Top
|
| 32
|
Rosalind Franklin
|
36,493
|
1,177
|
B
|
High
|
| 33
|
Herpes simplex virus
|
35,089
|
1,131
|
B
|
Top
|
| 34
|
Ebola
|
33,988
|
1,096
|
B
|
Top
|
| 35
|
SARS-CoV-2
|
33,880
|
1,092
|
B
|
Top
|
| 36
|
Yellow fever
|
33,523
|
1,081
|
B
|
Top
|
| 37
|
Common cold
|
29,762
|
960
|
GA
|
Top
|
| 38
|
Influenza A virus
|
29,283
|
944
|
B
|
Top
|
| 39
|
Gastroenteritis
|
29,272
|
944
|
GA
|
Top
|
| 40
|
HeLa
|
28,833
|
930
|
C
|
Mid
|
| 41
|
COVID-19 vaccine
|
28,604
|
922
|
C
|
Top
|
| 42
|
Foot-and-mouth disease
|
28,194
|
909
|
B
|
High
|
| 43
|
COVID-19 pandemic deaths
|
27,920
|
900
|
C
|
Low
|
| 44
|
History of HIV/AIDS
|
27,887
|
899
|
B
|
Top
|
| 45
|
Vomiting
|
27,861
|
898
|
C
|
Mid
|
| 46
|
Rhinovirus
|
27,848
|
898
|
C
|
High
|
| 47
|
Mpox
|
27,495
|
886
|
C
|
High
|
| 48
|
Variant Creutzfeldt–Jakob disease
|
26,559
|
856
|
B
|
High
|
| 49
|
Canine parvovirus
|
26,407
|
851
|
B
|
Top
|
| 50
|
Hepatitis B
|
25,891
|
835
|
GA
|
Top
|
| 51
|
Kaposi's sarcoma
|
25,012
|
806
|
C
|
Mid
|
| 52
|
Mumps
|
24,135
|
778
|
B
|
Top
|
| 53
|
Coronavirus
|
23,945
|
772
|
C
|
High
|
| 54
|
Rotavirus
|
23,689
|
764
|
FA
|
Top
|
| 55
|
Croup
|
23,557
|
759
|
GA
|
Top
|
| 56
|
Hepatitis C
|
23,480
|
757
|
GA
|
Top
|
| 57
|
COVID-19 pandemic by country and territory
|
22,856
|
737
|
List
|
Top
|
| 58
|
Canine distemper
|
22,171
|
715
|
B
|
Top
|
| 59
|
Vaccine
|
20,983
|
676
|
B
|
Top
|
| 60
|
Bacteriophage
|
20,768
|
669
|
B
|
Top
|
| 61
|
Rubella
|
19,920
|
642
|
B
|
Top
|
| 62
|
Timeline of the COVID-19 pandemic
|
19,807
|
638
|
List
|
Top
|
| 63
|
2023–2025 mpox epidemic
|
19,783
|
638
|
C
|
Mid
|
| 64
|
Cytomegalovirus
|
19,534
|
630
|
B
|
Top
|
| 65
|
West Nile virus
|
19,469
|
628
|
B
|
High
|
| 66
|
Genital wart
|
19,468
|
628
|
B
|
Top
|
| 67
|
Edward Jenner
|
18,860
|
608
|
B
|
High
|
| 68
|
Hepatitis A
|
18,581
|
599
|
C
|
Top
|
| 69
|
List of COVID-19 vaccine authorizations
|
18,522
|
597
|
List
|
Mid
|
| 70
|
Coxsackievirus
|
18,481
|
596
|
C
|
High
|
| 71
|
New York COVID-19 nursing home scandal
|
17,574
|
566
|
B
|
Low
|
| 72
|
Cold sore
|
17,474
|
563
|
C
|
Top
|
| 73
|
SARS
|
17,038
|
549
|
C
|
Top
|
| 74
|
COVID-19 pandemic in India
|
16,573
|
534
|
B
|
High
|
| 75
|
Smallpox vaccine
|
16,261
|
524
|
B
|
Mid
|
| 76
|
Genital herpes
|
15,996
|
516
|
C
|
High
|
| 77
|
List of deaths due to COVID-19
|
15,855
|
511
|
List
|
High
|
| 78
|
Epidemiology of HIV/AIDS
|
15,551
|
501
|
C
|
High
|
| 79
|
Pandemic
|
15,434
|
497
|
B
|
High
|
| 80
|
Hantavirus pulmonary syndrome
|
15,368
|
495
|
B
|
High
|
| 81
|
Varicella zoster virus
|
15,319
|
494
|
C
|
High
|
| 82
|
COVID-19 lab leak theory
|
15,230
|
491
|
B
|
Low
|
| 83
|
Cervical cancer
|
14,407
|
464
|
B
|
High
|
| 84
|
Enterovirus
|
14,331
|
462
|
C
|
High
|
| 85
|
Influenza vaccine
|
13,525
|
436
|
B
|
Top
|
| 86
|
COVID-19 misinformation
|
13,214
|
426
|
B
|
Low
|
| 87
|
HPV vaccine
|
12,997
|
419
|
B
|
High
|
| 88
|
HIV/AIDS in the United States
|
12,992
|
419
|
C
|
Low
|
| 89
|
Amantadine
|
12,873
|
415
|
C
|
High
|
| 90
|
2009 swine flu pandemic
|
12,322
|
397
|
GA
|
High
|
| 91
|
Orthohantavirus
|
12,254
|
395
|
B
|
Top
|
| 92
|
Sore throat
|
12,241
|
394
|
C
|
High
|
| 93
|
Messenger RNA
|
11,917
|
384
|
C
|
High
|
| 94
|
2002–2004 SARS outbreak
|
11,354
|
366
|
B
|
Mid
|
| 95
|
Operation Warp Speed
|
11,169
|
360
|
C
|
High
|
| 96
|
Influenza A virus subtype H1N1
|
11,107
|
358
|
C
|
Top
|
| 97
|
Marburg virus
|
11,053
|
356
|
C
|
High
|
| 98
|
Avian influenza
|
10,891
|
351
|
B
|
High
|
| 99
|
Origin of SARS-CoV-2
|
10,883
|
351
|
B
|
Mid
|
| 100
|
Retrovirus
|
10,442
|
336
|
C
|
Top
|
| 101
|
Zidovudine
|
10,228
|
329
|
B
|
High
|
| 102
|
Rabies virus
|
10,121
|
326
|
C
|
Top
|
| 103
|
Variants of SARS-CoV-2
|
10,118
|
326
|
C
|
Mid
|
| 104
|
SARS-CoV-2 Omicron variant
|
10,086
|
325
|
C
|
High
|
| 105
|
Anti-vaccine activism
|
9,987
|
322
|
B
|
Low
|
| 106
|
Zika virus
|
9,888
|
318
|
B
|
Top
|
| 107
|
COVID-19 pandemic in the United Kingdom
|
9,776
|
315
|
C
|
Low
|
| 108
|
Varicella vaccine
|
9,735
|
314
|
B
|
Top
|
| 109
|
Herpesviridae
|
9,643
|
311
|
C
|
Top
|
| 110
|
Feline leukemia virus
|
9,507
|
306
|
C
|
High
|
| 111
|
Timeline of HIV/AIDS
|
9,402
|
303
|
List
|
Mid
|
| 112
|
Feline immunodeficiency virus
|
9,275
|
299
|
C
|
High
|
| 113
|
Rinderpest
|
9,259
|
298
|
B
|
High
|
| 114
|
Hong Kong flu
|
9,084
|
293
|
C
|
Low
|
| 115
|
Respiratory syncytial virus vaccine
|
8,957
|
288
|
B
|
Mid
|
| 116
|
Moderna
|
8,869
|
286
|
C
|
Low
|
| 117
|
Remdesivir
|
8,854
|
285
|
C
|
High
|
| 118
|
Western African Ebola epidemic
|
8,834
|
284
|
GA
|
Mid
|
| 119
|
Interferon
|
8,600
|
277
|
B
|
Top
|
| 120
|
Feline infectious peritonitis
|
8,509
|
274
|
C
|
High
|
| 121
|
Shope papilloma virus
|
8,405
|
271
|
C
|
Mid
|
| 122
|
Rhinorrhea
|
8,233
|
265
|
C
|
High
|
| 123
|
Vaccination
|
8,175
|
263
|
B
|
Top
|
| 124
|
Japanese encephalitis
|
8,157
|
263
|
C
|
High
|
| 125
|
Myxomatosis
|
7,947
|
256
|
GA
|
High
|
| 126
|
1889–1890 pandemic
|
7,852
|
253
|
C
|
Mid
|
| 127
|
Vaccine hesitancy
|
7,685
|
247
|
B
|
High
|
| 128
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
7,561
|
243
|
C
|
Low
|
| 129
|
Adenoviridae
|
7,500
|
241
|
B
|
High
|
| 130
|
Antiviral drug
|
7,380
|
238
|
B
|
Top
|
| 131
|
Poliovirus
|
7,317
|
236
|
GA
|
High
|
| 132
|
Tobacco mosaic virus
|
7,252
|
233
|
C
|
High
|
| 133
|
SARS-CoV-1
|
7,108
|
229
|
C
|
High
|
| 134
|
Rabies in animals
|
7,065
|
227
|
C
|
High
|
| 135
|
Gardasil
|
7,063
|
227
|
B
|
High
|
| 136
|
Index case
|
7,041
|
227
|
Start
|
Low
|
| 137
|
Subacute sclerosing panencephalitis
|
6,943
|
223
|
C
|
Mid
|
| 138
|
Nipah virus
|
6,822
|
220
|
Start
|
Mid
|
| 139
|
Alphapithovirus
|
6,758
|
218
|
C
|
High
|
| 140
|
Walter Reed
|
6,756
|
217
|
Start
|
Low
|
| 141
|
Virus classification
|
6,749
|
217
|
C
|
Top
|
| 142
|
Influenza B virus
|
6,713
|
216
|
C
|
High
|
| 143
|
Roseola
|
6,629
|
213
|
C
|
High
|
| 144
|
Viral hemorrhagic fever
|
6,620
|
213
|
C
|
High
|
| 145
|
Marburg virus disease
|
6,522
|
210
|
C
|
High
|
| 146
|
Human parainfluenza viruses
|
6,432
|
207
|
C
|
Mid
|
| 147
|
Viral disease
|
6,388
|
206
|
List
|
Top
|
| 148
|
Swine influenza
|
6,378
|
205
|
B
|
High
|
| 149
|
COVID-19 pandemic in the Philippines
|
6,328
|
204
|
B
|
Low
|
| 150
|
Subtypes of HIV
|
6,317
|
203
|
C
|
High
|
| 151
|
Influenza A virus subtype H5N1
|
6,189
|
199
|
B
|
Top
|
| 152
|
COVID-19 pandemic in Australia
|
6,146
|
198
|
B
|
Low
|
| 153
|
Zaire ebolavirus
|
6,130
|
197
|
C
|
Top
|
| 154
|
African swine fever virus
|
6,061
|
195
|
C
|
High
|
| 155
|
COVID-19 vaccination mandates in the United States
|
6,043
|
194
|
Start
|
Low
|
| 156
|
1978 smallpox outbreak in the United Kingdom
|
5,901
|
190
|
B
|
Low
|
| 157
|
Incertae sedis
|
5,836
|
188
|
C
|
Low
|
| 158
|
Bioterrorism
|
5,816
|
187
|
B
|
Low
|
| 159
|
Orthopoxvirus
|
5,718
|
184
|
C
|
High
|
| 160
|
Measles vaccine
|
5,711
|
184
|
C
|
Low
|
| 161
|
COVID-19 pandemic in mainland China
|
5,693
|
183
|
C
|
High
|
| 162
|
Phage therapy
|
5,661
|
182
|
C
|
Top
|
| 163
|
DNA polymerase
|
5,618
|
181
|
C
|
Top
|
| 164
|
Polio eradication
|
5,525
|
178
|
B
|
Mid
|
| 165
|
Orthomyxoviridae
|
5,518
|
178
|
B
|
High
|
| 166
|
Cowpox
|
5,495
|
177
|
C
|
Mid
|
| 167
|
Variolation
|
5,495
|
177
|
C
|
High
|
| 168
|
B virus
|
5,481
|
176
|
C
|
Mid
|
| 169
|
SV40
|
5,469
|
176
|
C
|
Mid
|
| 170
|
COVID-19 pandemic in New Zealand
|
5,467
|
176
|
C
|
Low
|
| 171
|
Human metapneumovirus
|
5,429
|
175
|
C
|
High
|
| 172
|
Lady Mary Wortley Montagu
|
5,383
|
173
|
B
|
Low
|
| 173
|
MERS
|
5,369
|
173
|
B
|
High
|
| 174
|
Lyssavirus
|
5,346
|
172
|
C
|
Mid
|
| 175
|
Nasal congestion
|
5,346
|
172
|
Start
|
High
|
| 176
|
Hepatitis C virus
|
5,218
|
168
|
C
|
Top
|
| 177
|
Obelisk (biology)
|
5,203
|
167
|
Start
|
High
|
| 178
|
Human T-lymphotropic virus 1
|
5,156
|
166
|
C
|
High
|
| 179
|
Human herpesvirus 6
|
5,150
|
166
|
C
|
High
|
| 180
|
2019 Samoa measles outbreak
|
5,118
|
165
|
C
|
Low
|
| 181
|
Dengue virus
|
5,050
|
162
|
B
|
Top
|
| 182
|
List of antiviral drugs
|
5,013
|
161
|
List
|
High
|
| 183
|
Wuhan Institute of Virology
|
4,884
|
157
|
C
|
Mid
|
| 184
|
Feline calicivirus
|
4,874
|
157
|
C
|
Top
|
| 185
|
RNA interference
|
4,852
|
156
|
FA
|
High
|
| 186
|
Viroid
|
4,803
|
154
|
C
|
High
|
| 187
|
Severe acute respiratory syndrome coronavirus 2
|
4,762
|
153
|
Redirect
|
NA
|
| 188
|
Influenza A virus subtype H3N2
|
4,746
|
153
|
C
|
High
|
| 189
|
Peter Daszak
|
4,703
|
151
|
Start
|
Low
|
| 190
|
Papillomaviridae
|
4,625
|
149
|
B
|
Top
|
| 191
|
Rift Valley fever
|
4,611
|
148
|
C
|
High
|
| 192
|
Parvovirus B19
|
4,597
|
148
|
C
|
Mid
|
| 193
|
West Nile fever
|
4,567
|
147
|
C
|
High
|
| 194
|
COVID-19 pandemic in Victoria
|
4,546
|
146
|
C
|
Low
|
| 195
|
COVID-19 pandemic in Canada
|
4,537
|
146
|
B
|
Mid
|
| 196
|
Crimean–Congo hemorrhagic fever
|
4,515
|
145
|
C
|
High
|
| 197
|
Host (biology)
|
4,493
|
144
|
GA
|
High
|
| 198
|
RNA polymerase
|
4,477
|
144
|
B
|
High
|
| 199
|
Merkel-cell carcinoma
|
4,461
|
143
|
C
|
Mid
|
| 200
|
Tick-borne encephalitis
|
4,410
|
142
|
Start
|
Low
|
| 201
|
Lassa fever
|
4,396
|
141
|
B
|
High
|
| 202
|
Reverse transcriptase
|
4,388
|
141
|
B
|
Top
|
| 203
|
Yellow fever vaccine
|
4,356
|
140
|
C
|
High
|
| 204
|
Lentivirus
|
4,342
|
140
|
C
|
Mid
|
| 205
|
COVID-19 vaccination in the United States
|
4,337
|
139
|
Start
|
Low
|
| 206
|
Hepatitis B virus
|
4,311
|
139
|
C
|
Top
|
| 207
|
COVID-19 testing
|
4,295
|
138
|
B
|
Low
|
| 208
|
Simian immunodeficiency virus
|
4,287
|
138
|
C
|
High
|
| 209
|
COVID-19 pandemic in Italy
|
4,249
|
137
|
B
|
Mid
|
| 210
|
Pithovirus
|
4,241
|
136
|
Redirect
|
NA
|
| 211
|
COVID-19 vaccine misinformation and hesitancy
|
4,223
|
136
|
B
|
Top
|
| 212
|
Virology
|
4,167
|
134
|
B
|
Top
|
| 213
|
Influenza pandemic
|
4,156
|
134
|
B
|
Top
|
| 214
|
Baltimore classification
|
4,126
|
133
|
GA
|
Top
|
| 215
|
Henipavirus
|
4,112
|
132
|
C
|
High
|
| 216
|
Ebolavirus
|
4,088
|
131
|
C
|
Mid
|
| 217
|
Human polyomavirus 2
|
4,066
|
131
|
C
|
High
|
| 218
|
2001 United Kingdom foot-and-mouth outbreak
|
4,021
|
129
|
C
|
Mid
|
| 219
|
Herpes simplex encephalitis
|
4,002
|
129
|
Start
|
Low
|
| 220
|
Monkeypox virus
|
3,947
|
127
|
C
|
Mid
|
| 221
|
COVID-19 pandemic in Japan
|
3,916
|
126
|
C
|
Low
|
| 222
|
Timeline of the COVID-19 pandemic in 2019
|
3,903
|
125
|
List
|
High
|
| 223
|
Hershey–Chase experiment
|
3,899
|
125
|
C
|
Mid
|
| 224
|
Attenuated vaccine
|
3,894
|
125
|
C
|
High
|
| 225
|
Gain-of-function research
|
3,877
|
125
|
C
|
High
|
| 226
|
Parvoviridae
|
3,856
|
124
|
B
|
Mid
|
| 227
|
Australian bat lyssavirus
|
3,820
|
123
|
C
|
Low
|
| 228
|
History of smallpox
|
3,817
|
123
|
C
|
Mid
|
| 229
|
Hepatitis E
|
3,815
|
123
|
GA
|
High
|
| 230
|
Adeno-associated virus
|
3,806
|
122
|
B
|
High
|
| 231
|
BK virus
|
3,798
|
122
|
B
|
Low
|
| 232
|
History of COVID-19 vaccine development
|
3,787
|
122
|
C
|
Low
|
| 233
|
RNA virus
|
3,758
|
121
|
B
|
Top
|
| 234
|
Bluetongue disease
|
3,724
|
120
|
B
|
High
|
| 235
|
Malaysian movement control order
|
3,714
|
119
|
B
|
Low
|
| 236
|
Ebola virus cases in the United States
|
3,712
|
119
|
C
|
High
|
| 237
|
Viral hepatitis
|
3,706
|
119
|
C
|
High
|
| 238
|
Non-cellular life
|
3,682
|
118
|
Start
|
Low
|
| 239
|
Measles virus
|
3,679
|
118
|
C
|
Top
|
| 240
|
Adenovirus infection
|
3,679
|
118
|
C
|
Mid
|
| 241
|
Capsid
|
3,651
|
117
|
C
|
Top
|
| 242
|
Pandemic H1N1/09 virus
|
3,627
|
117
|
C
|
Mid
|
| 243
|
COVID-19 pandemic in New York City
|
3,596
|
116
|
C
|
Low
|
| 244
|
Measles resurgence in the United States
|
3,574
|
115
|
C
|
Low
|
| 245
|
Kaposi's sarcoma-associated herpesvirus
|
3,566
|
115
|
C
|
High
|
| 246
|
Oncovirus
|
3,566
|
115
|
C
|
Top
|
| 247
|
Lumpy skin disease
|
3,563
|
114
|
C
|
Mid
|
| 248
|
Poxviridae
|
3,562
|
114
|
C
|
High
|
| 249
|
Feed a cold, starve a fever
|
3,487
|
112
|
C
|
Low
|
| 250
|
Lysogenic cycle
|
3,476
|
112
|
C
|
High
|
| 251
|
Vaccine shedding
|
3,461
|
111
|
Start
|
Mid
|
| 252
|
Ivermectin during the COVID-19 pandemic
|
3,421
|
110
|
B
|
Low
|
| 253
|
Symptoms of COVID-19
|
3,399
|
109
|
C
|
Low
|
| 254
|
HIV trial in Libya
|
3,369
|
108
|
B
|
Low
|
| 255
|
Vaccinia
|
3,367
|
108
|
C
|
High
|
| 256
|
Deployment of COVID-19 vaccines
|
3,351
|
108
|
C
|
High
|
| 257
|
Carcinogenesis
|
3,318
|
107
|
B
|
Mid
|
| 258
|
Dengue vaccine
|
3,291
|
106
|
C
|
Low
|
| 259
|
Rhabdoviridae
|
3,282
|
105
|
C
|
High
|
| 260
|
Rabbit hemorrhagic disease
|
3,263
|
105
|
B
|
Mid
|
| 261
|
Virulent Newcastle disease
|
3,245
|
104
|
C
|
High
|
| 262
|
2022–2023 mpox outbreak
|
3,232
|
104
|
B
|
Mid
|
| 263
|
Hepatitis D
|
3,225
|
104
|
C
|
Mid
|
| 264
|
DNA virus
|
3,224
|
104
|
C
|
Top
|
| 265
|
HIV vaccine development
|
3,222
|
103
|
C
|
Mid
|
| 266
|
COVID-19 pandemic in Russia
|
3,199
|
103
|
C
|
Low
|
| 267
|
Timeline of human vaccines
|
3,191
|
102
|
List
|
Low
|
| 268
|
COVID-19 pandemic in North Korea
|
3,190
|
102
|
B
|
Mid
|
| 269
|
Escherichia virus T4
|
3,185
|
102
|
Start
|
Mid
|
| 270
|
Spike protein
|
3,178
|
102
|
Start
|
Low
|
| 271
|
Lambda phage
|
3,154
|
101
|
B
|
High
|
| 272
|
Viral envelope
|
3,145
|
101
|
Start
|
Top
|
| 273
|
SARS-CoV-2 Delta variant
|
3,142
|
101
|
C
|
Mid
|
| 274
|
Viral encephalitis
|
3,139
|
101
|
B
|
High
|
| 275
|
Coronavirus spike protein
|
3,132
|
101
|
Start
|
Low
|
| 276
|
1957–1958 influenza pandemic
|
3,127
|
100
|
C
|
Mid
|
| 277
|
MOG antibody disease
|
3,126
|
100
|
C
|
Mid
|
| 278
|
Rotavirus vaccine
|
3,119
|
100
|
C
|
High
|
| 279
|
Arbovirus
|
3,055
|
98
|
C
|
Top
|
| 280
|
Picornavirus
|
3,007
|
97
|
B
|
Mid
|
| 281
|
Flu season
|
2,989
|
96
|
C
|
High
|
| 282
|
Eastern equine encephalitis
|
2,985
|
96
|
B
|
Mid
|
| 283
|
Giant virus
|
2,950
|
95
|
C
|
High
|
| 284
|
Canine distemper virus
|
2,921
|
94
|
Redirect
|
NA
|
| 285
|
Endogenous retrovirus
|
2,921
|
94
|
C
|
Mid
|
| 286
|
Flaviviridae
|
2,903
|
93
|
Start
|
High
|
| 287
|
Human cytomegalovirus
|
2,882
|
92
|
C
|
High
|
| 288
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
2,881
|
92
|
C
|
Mid
|
| 289
|
List of Ebola outbreaks
|
2,872
|
92
|
List
|
Low
|
| 290
|
Bat virome
|
2,844
|
91
|
GA
|
High
|
| 291
|
Congenital rubella syndrome
|
2,835
|
91
|
Start
|
Mid
|
| 292
|
Koplik's spots
|
2,809
|
90
|
C
|
Mid
|
| 293
|
Orthoflavivirus
|
2,777
|
89
|
B
|
High
|
| 294
|
Zika fever
|
2,771
|
89
|
B
|
High
|
| 295
|
History of virology
|
2,749
|
88
|
B
|
Top
|
| 296
|
1793 Philadelphia yellow fever epidemic
|
2,746
|
88
|
C
|
Low
|
| 297
|
Transduction (genetics)
|
2,741
|
88
|
C
|
High
|
| 298
|
COVID-19 pandemic in Singapore
|
2,716
|
87
|
B
|
High
|
| 299
|
List of biosafety level 4 organisms
|
2,711
|
87
|
List
|
Low
|
| 300
|
Metagenomics
|
2,705
|
87
|
GA
|
High
|
| 301
|
COVID-19 pandemic in the Republic of Ireland
|
2,643
|
85
|
C
|
Low
|
| 302
|
Sapovirus
|
2,639
|
85
|
C
|
High
|
| 303
|
Flat wart
|
2,637
|
85
|
Stub
|
Mid
|
| 304
|
2020–2025 H5N1 outbreak
|
2,624
|
84
|
C
|
Low
|
| 305
|
Sea star wasting disease
|
2,616
|
84
|
C
|
Mid
|
| 306
|
COVID-19 pandemic in Europe
|
2,615
|
84
|
C
|
Low
|
| 307
|
Positive-strand RNA virus
|
2,613
|
84
|
C
|
High
|
| 308
|
Viral pneumonia
|
2,587
|
83
|
C
|
High
|
| 309
|
Viral evolution
|
2,575
|
83
|
C
|
High
|
| 310
|
Riboviria
|
2,569
|
82
|
B
|
Top
|
| 311
|
Lytic cycle
|
2,545
|
82
|
C
|
High
|
| 312
|
Richard H. Ebright
|
2,535
|
81
|
Start
|
Mid
|
| 313
|
Diagnosis of HIV/AIDS
|
2,531
|
81
|
B
|
High
|
| 314
|
COVID-19 pandemic on cruise ships
|
2,524
|
81
|
B
|
High
|
| 315
|
Hendra virus
|
2,516
|
81
|
Start
|
Mid
|
| 316
|
Virion
|
2,496
|
80
|
Start
|
Top
|
| 317
|
Paramyxoviridae
|
2,481
|
80
|
C
|
High
|
| 318
|
COVID-19 pandemic in New South Wales
|
2,479
|
79
|
B
|
Low
|
| 319
|
Sense (molecular biology)
|
2,477
|
79
|
C
|
High
|
| 320
|
Orf (disease)
|
2,455
|
79
|
Start
|
Low
|
| 321
|
Echovirus
|
2,452
|
79
|
List
|
Mid
|
| 322
|
Nipah virus infection
|
2,448
|
78
|
B
|
High
|
| 323
|
Filoviridae
|
2,447
|
78
|
Start
|
High
|
| 324
|
Disease X
|
2,446
|
78
|
GA
|
Low
|
| 325
|
Rubella virus
|
2,445
|
78
|
C
|
High
|
| 326
|
Coxsackie A virus
|
2,440
|
78
|
Start
|
Mid
|
| 327
|
Virulence
|
2,434
|
78
|
C
|
High
|
| 328
|
Smallpox virus retention debate
|
2,434
|
78
|
Start
|
Low
|
| 329
|
COVID-19 pandemic on Diamond Princess
|
2,424
|
78
|
Start
|
Low
|
| 330
|
Natural reservoir
|
2,421
|
78
|
C
|
High
|
| 331
|
Mimivirus
|
2,408
|
77
|
C
|
Mid
|
| 332
|
Feline coronavirus
|
2,395
|
77
|
C
|
Mid
|
| 333
|
SARS-related coronavirus
|
2,362
|
76
|
C
|
High
|
| 334
|
Eczema herpeticum
|
2,357
|
76
|
Start
|
Low
|
| 335
|
COVID-19 vaccination in the United Kingdom
|
2,324
|
74
|
C
|
Low
|
| 336
|
Negative-strand RNA virus
|
2,313
|
74
|
B
|
Mid
|
| 337
|
COVID-19 pandemic in South Africa
|
2,312
|
74
|
B
|
Mid
|
| 338
|
COVID-19 pandemic in California
|
2,310
|
74
|
C
|
Mid
|
| 339
|
Superinfection
|
2,296
|
74
|
Stub
|
Mid
|
| 340
|
2025 Southwest United States measles outbreak
|
2,288
|
73
|
Start
|
Low
|
| 341
|
COVID-19 vaccination in India
|
2,287
|
73
|
C
|
Low
|
| 342
|
GS-441524
|
2,282
|
73
|
Start
|
Low
|
| 343
|
Reston virus
|
2,278
|
73
|
C
|
Low
|
| 344
|
Lamivudine
|
2,270
|
73
|
C
|
Mid
|
| 345
|
Discrimination against people with HIV/AIDS
|
2,267
|
73
|
C
|
High
|
| 346
|
Ebola virus
|
2,267
|
73
|
Redirect
|
NA
|
| 347
|
Carnivore protoparvovirus 1
|
2,266
|
73
|
Start
|
Mid
|
| 348
|
Superspreading event
|
2,266
|
73
|
C
|
High
|
| 349
|
COVID-19 pandemic in Sweden
|
2,264
|
73
|
B
|
Low
|
| 350
|
Inclusion bodies
|
2,259
|
72
|
C
|
High
|
| 351
|
Coxsackie B virus
|
2,221
|
71
|
C
|
Mid
|
| 352
|
Viral shedding
|
2,206
|
71
|
Start
|
High
|
| 353
|
MERS-related coronavirus
|
2,204
|
71
|
B
|
High
|
| 354
|
Strain (biology)
|
2,189
|
70
|
C
|
High
|
| 355
|
Virgin cleansing myth
|
2,160
|
69
|
Start
|
Low
|
| 356
|
COVID-19 pandemic in France
|
2,156
|
69
|
B
|
Mid
|
| 357
|
Phage display
|
2,145
|
69
|
C
|
Mid
|
| 358
|
List of unproven methods against COVID-19
|
2,145
|
69
|
List
|
Mid
|
| 359
|
COVID-19 pandemic in Germany
|
2,144
|
69
|
C
|
Low
|
| 360
|
Ebola vaccine
|
2,093
|
67
|
C
|
Mid
|
| 361
|
Orthornavirae
|
2,093
|
67
|
B
|
High
|
| 362
|
HIV/AIDS in Russia
|
2,071
|
66
|
Start
|
Low
|
| 363
|
Spillover infection
|
2,069
|
66
|
Start
|
Mid
|
| 364
|
Timeline of the COVID-19 pandemic in January 2020
|
2,059
|
66
|
List
|
High
|
| 365
|
COVID-19 pandemic in Hubei
|
2,053
|
66
|
C
|
Mid
|
| 366
|
Viral replication
|
2,052
|
66
|
C
|
Top
|
| 367
|
Enterovirus 71
|
2,036
|
65
|
Start
|
High
|
| 368
|
COVID-19 pandemic in Malaysia
|
2,023
|
65
|
B
|
High
|
| 369
|
Deer cutaneous fibroma
|
2,020
|
65
|
Start
|
Low
|
| 370
|
1976 Zaire Ebola virus outbreak
|
2,008
|
64
|
C
|
Low
|
| 371
|
Alphavirus
|
1,987
|
64
|
C
|
Mid
|
| 372
|
SARS-CoV-2 Alpha variant
|
1,980
|
63
|
C
|
Low
|
| 373
|
Antibody-dependent enhancement
|
1,971
|
63
|
C
|
High
|
| 374
|
Hantavirus hemorrhagic fever with renal syndrome
|
1,965
|
63
|
B
|
High
|
| 375
|
Vaccine misinformation
|
1,965
|
63
|
C
|
Mid
|
| 376
|
COVID-19 pandemic in South Korea
|
1,956
|
63
|
B
|
Low
|
| 377
|
Marek's disease
|
1,955
|
63
|
C
|
Mid
|
| 378
|
1977 Russian flu
|
1,944
|
62
|
C
|
Mid
|
| 379
|
Oncolytic virus
|
1,941
|
62
|
B
|
Mid
|
| 380
|
Polyomaviridae
|
1,940
|
62
|
C
|
High
|
| 381
|
COVID-19 pandemic in New York (state)
|
1,940
|
62
|
C
|
Low
|
| 382
|
Vertically transmitted infection
|
1,933
|
62
|
C
|
High
|
| 383
|
Virus latency
|
1,930
|
62
|
C
|
High
|
| 384
|
Mumps virus
|
1,907
|
61
|
B
|
High
|
| 385
|
Timeline of the COVID-19 pandemic in March 2020
|
1,906
|
61
|
List
|
High
|
| 386
|
Macfarlane Burnet
|
1,892
|
61
|
C
|
Low
|
| 387
|
Oropouche fever
|
1,892
|
61
|
C
|
Low
|
| 388
|
Jonathan Van-Tam
|
1,879
|
60
|
C
|
Low
|
| 389
|
Molnupiravir
|
1,872
|
60
|
C
|
Mid
|
| 390
|
Herpes simplex virus 1
|
1,867
|
60
|
Start
|
Mid
|
| 391
|
Powassan virus
|
1,863
|
60
|
C
|
Mid
|
| 392
|
White House Coronavirus Task Force
|
1,854
|
59
|
C
|
Low
|
| 393
|
Lassa virus
|
1,826
|
58
|
C
|
Mid
|
| 394
|
Human coronavirus OC43
|
1,799
|
58
|
C
|
Mid
|
| 395
|
COVID-19 pandemic in Hong Kong
|
1,798
|
58
|
C
|
Low
|
| 396
|
Structure and genome of HIV
|
1,792
|
57
|
B
|
High
|
| 397
|
White House COVID-19 outbreak
|
1,781
|
57
|
C
|
Low
|
| 398
|
Rolling circle replication
|
1,780
|
57
|
C
|
Mid
|
| 399
|
Variably protease-sensitive prionopathy
|
1,777
|
57
|
Start
|
Low
|
| 400
|
COVID-19 pandemic in Spain
|
1,777
|
57
|
C
|
Low
|
| 401
|
COVID-19 pandemic in Pakistan
|
1,774
|
57
|
B
|
Low
|
| 402
|
History of coronavirus
|
1,774
|
57
|
B
|
Mid
|
| 403
|
Pandoravirus
|
1,764
|
56
|
Start
|
High
|
| 404
|
Innate resistance to HIV
|
1,761
|
56
|
C
|
High
|
| 405
|
Caliciviridae
|
1,752
|
56
|
C
|
Mid
|
| 406
|
Viral load
|
1,740
|
56
|
Start
|
Mid
|
| 407
|
Herpes simplex virus 2
|
1,734
|
55
|
Start
|
Mid
|
| 408
|
HBsAg
|
1,726
|
55
|
Start
|
High
|
| 409
|
RNA-dependent RNA polymerase
|
1,703
|
54
|
C
|
Top
|
| 410
|
Timeline of the COVID-19 pandemic in Canada
|
1,699
|
54
|
B
|
Mid
|
| 411
|
Arenavirus
|
1,687
|
54
|
C
|
High
|
| 412
|
Intracellular parasite
|
1,682
|
54
|
Start
|
Mid
|
| 413
|
Feline viral rhinotracheitis
|
1,681
|
54
|
B
|
Top
|
| 414
|
Astrovirus
|
1,675
|
54
|
B
|
Low
|
| 415
|
Timeline of the COVID-19 pandemic in New York City
|
1,668
|
53
|
C
|
Low
|
| 416
|
Human herpesvirus 7
|
1,652
|
53
|
C
|
Mid
|
| 417
|
Baculoviridae
|
1,651
|
53
|
C
|
Mid
|
| 418
|
Phi X 174
|
1,629
|
52
|
Start
|
Mid
|
| 419
|
Realm (virology)
|
1,618
|
52
|
B
|
Top
|
| 420
|
COVID-19 pandemic in Brazil
|
1,618
|
52
|
C
|
Low
|
| 421
|
2015–16 Zika virus epidemic
|
1,616
|
52
|
B
|
Mid
|
| 422
|
735–737 Japanese smallpox epidemic
|
1,614
|
52
|
C
|
Low
|
| 423
|
COVID-19 pandemic in Africa
|
1,612
|
52
|
Start
|
Low
|
| 424
|
Anthony Epstein
|
1,609
|
51
|
Start
|
Mid
|
| 425
|
1837 Great Plains smallpox epidemic
|
1,600
|
51
|
C
|
Low
|
| 426
|
COVID-19 pandemic in North America
|
1,600
|
51
|
C
|
Mid
|
| 427
|
Coronaviridae
|
1,595
|
51
|
Start
|
High
|
| 428
|
Molluscum contagiosum virus
|
1,595
|
51
|
C
|
Mid
|
| 429
|
Jeffery Taubenberger
|
1,586
|
51
|
C
|
Low
|
| 430
|
UK COVID-19 Inquiry
|
1,555
|
50
|
C
|
Low
|
| 431
|
2020–21 Singapore circuit breaker measures
|
1,547
|
49
|
C
|
Low
|
| 432
|
Primate T-lymphotropic virus
|
1,544
|
49
|
C
|
High
|
| 433
|
List of diseases of the honey bee
|
1,521
|
49
|
List
|
High
|
| 434
|
Lymphocytic choriomeningitis
|
1,505
|
48
|
B
|
Mid
|
| 435
|
Viral vector vaccine
|
1,483
|
47
|
Start
|
Low
|
| 436
|
Emerging infectious disease
|
1,466
|
47
|
C
|
Low
|
| 437
|
Banana bunchy top virus
|
1,465
|
47
|
C
|
Mid
|
| 438
|
Caudoviricetes
|
1,463
|
47
|
Start
|
Top
|
| 439
|
Transmission of COVID-19
|
1,452
|
46
|
C
|
High
|
| 440
|
Enhanced community quarantine in Luzon
|
1,451
|
46
|
B
|
Low
|
| 441
|
Coalition for Epidemic Preparedness Innovations
|
1,450
|
46
|
GA
|
Low
|
| 442
|
Max Theiler
|
1,447
|
46
|
C
|
Low
|
| 443
|
Virophage
|
1,443
|
46
|
C
|
Mid
|
| 444
|
Negri body
|
1,440
|
46
|
Start
|
Mid
|
| 445
|
Psittacine beak and feather disease
|
1,440
|
46
|
Start
|
Mid
|
| 446
|
Chronic active EBV infection
|
1,435
|
46
|
Start
|
Low
|
| 447
|
Bunyaviricetes
|
1,434
|
46
|
C
|
Mid
|
| 448
|
Kyasanur Forest disease
|
1,429
|
46
|
B
|
Mid
|
| 449
|
Duplodnaviria
|
1,429
|
46
|
B
|
Top
|
| 450
|
HIV/AIDS in Thailand
|
1,426
|
46
|
Start
|
Low
|
| 451
|
Neonatal herpes
|
1,416
|
45
|
Start
|
High
|
| 452
|
Neurotropic virus
|
1,411
|
45
|
Start
|
High
|
| 453
|
COVID-19 pandemic in Israel
|
1,402
|
45
|
C
|
Mid
|
| 454
|
Cancer in cats
|
1,400
|
45
|
C
|
Mid
|
| 455
|
COVID-19 pandemic in Indonesia
|
1,397
|
45
|
C
|
Low
|
| 456
|
Enterovirus 68
|
1,386
|
44
|
C
|
Mid
|
| 457
|
Harald zur Hausen
|
1,383
|
44
|
B
|
Mid
|
| 458
|
DNA vaccine
|
1,380
|
44
|
B
|
Low
|
| 459
|
Plant virus
|
1,377
|
44
|
C
|
Top
|
| 460
|
COVID-19 pandemic in Florida
|
1,362
|
43
|
C
|
Low
|
| 461
|
COVID-19 pandemic in Peru
|
1,358
|
43
|
Start
|
Mid
|
| 462
|
COVID-19 pandemic in Tamil Nadu
|
1,353
|
43
|
C
|
Low
|
| 463
|
Reverse-transcriptase inhibitor
|
1,338
|
43
|
C
|
High
|
| 464
|
Parvovirus
|
1,330
|
42
|
Redirect
|
NA
|
| 465
|
Ross River virus
|
1,326
|
42
|
C
|
Mid
|
| 466
|
History of yellow fever
|
1,314
|
42
|
Start
|
Low
|
| 467
|
1993 Four Corners hantavirus outbreak
|
1,311
|
42
|
GA
|
High
|
| 468
|
Sin Nombre virus
|
1,310
|
42
|
B
|
High
|
| 469
|
COVID-19 pandemic in Maharashtra
|
1,304
|
42
|
C
|
Low
|
| 470
|
Viremia
|
1,301
|
41
|
Start
|
High
|
| 471
|
Influenza C virus
|
1,294
|
41
|
C
|
Mid
|
| 472
|
Feline spongiform encephalopathy
|
1,293
|
41
|
C
|
Low
|
| 473
|
Bolivian hemorrhagic fever
|
1,292
|
41
|
Start
|
Mid
|
| 474
|
Pleomorphism (microbiology)
|
1,290
|
41
|
C
|
High
|
| 475
|
Reovirales
|
1,287
|
41
|
C
|
Mid
|
| 476
|
Double-stranded RNA
|
1,282
|
41
|
Start
|
Mid
|
| 477
|
Coronavirus diseases
|
1,281
|
41
|
List
|
Low
|
| 478
|
Human coronavirus NL63
|
1,249
|
40
|
C
|
Low
|
| 479
|
Virus-like particle
|
1,247
|
40
|
C
|
Mid
|
| 480
|
HIV superinfection
|
1,234
|
39
|
C
|
Mid
|
| 481
|
Introduction to viruses
|
1,227
|
39
|
FA
|
Top
|
| 482
|
Foot-and-mouth disease virus
|
1,220
|
39
|
Start
|
Mid
|
| 483
|
Pigeon pox
|
1,213
|
39
|
Start
|
Low
|
| 484
|
COVID-19 pandemic in Vietnam
|
1,213
|
39
|
C
|
Low
|
| 485
|
COVID-19 pandemic in China
|
1,212
|
39
|
C
|
Mid
|
| 486
|
2025 Kasaï Province Ebola outbreak
|
1,206
|
38
|
Start
|
Low
|
| 487
|
HA-tag
|
1,199
|
38
|
Start
|
High
|
| 488
|
O'nyong'nyong virus
|
1,193
|
38
|
Start
|
Mid
|
| 489
|
Satellite (biology)
|
1,188
|
38
|
Start
|
Mid
|
| 490
|
COVID-19 vaccination in Australia
|
1,180
|
38
|
B
|
Mid
|
| 491
|
List of sexually transmitted infections by prevalence
|
1,175
|
37
|
List
|
Low
|
| 492
|
Herpes simplex research
|
1,170
|
37
|
B
|
Mid
|
| 493
|
Media portrayal of HIV/AIDS
|
1,169
|
37
|
B
|
Low
|
| 494
|
Classical swine fever
|
1,164
|
37
|
C
|
High
|
| 495
|
SFTS virus
|
1,160
|
37
|
C
|
Mid
|
| 496
|
Pseudorabies
|
1,159
|
37
|
C
|
High
|
| 497
|
Venezuelan equine encephalitis virus
|
1,157
|
37
|
Start
|
Mid
|
| 498
|
COVID-19 pandemic in Bangladesh
|
1,155
|
37
|
C
|
Mid
|
| 499
|
Treatment and management of COVID-19
|
1,154
|
37
|
C
|
Mid
|
| 500
|
Koilocyte
|
1,151
|
37
|
C
|
Low
|